UPMC's ID Connect has absorbed Merck & Co's Ilúm Health Solutions to boost its client base and services offering.
Infectious Disease (ID) Connect, a US-based telemedicine spinout of University of Pittsburgh Medical Center (UPMC), has merged with infectious disease management service provider Ilúm Health Solutions, a division of pharmaceutical firm Merck & Co.
UPMC and Merck will both inject $5m into the merged business, investing through tech transfer office UPMC Enterprises and corporate venturing fund Merck Global Health Innovation Fund respectively. UPMC will retain a majority stake in the new company.
…
